Skip to main content
Erschienen in: Journal of General Internal Medicine 8/2019

22.04.2019 | Concise Research Reports

The Association of EHR Drug Safety Alerts and Co-prescribing of Opioids and Benzodiazepines

verfasst von: Laura Barrie Smith, BA, Ezra Golberstein, PhD, Kelly Anderson, RN, BSN, Tori Christiaansen, MD, Nicole Paterson, PharmD BCPS, Sonja Short, MD, Hannah T. Neprash, PhD

Erschienen in: Journal of General Internal Medicine | Ausgabe 8/2019

Einloggen, um Zugang zu erhalten

Excerpt

Concurrent opioid and benzodiazepine use is associated with an increased risk of overdose, compared with opioid users who do not use benzodiazepines.1,2 Reflecting this safety concern, the Center for Disease Control and Prevention’s 2016 chronic pain guideline recommended against co-prescribing opioids and benzodiazepines.3 Nevertheless, clinicians frequently co-prescribe these medications. A recent estimate finds that 17% of opioid users concurrently use a benzodiazepine.1
Literatur
1.
Zurück zum Zitat Sun EC, Dixit A, Humphreys K, Darnall BD, Baker LC, Mackey S. Association between concurrent use of prescription opioids and benzodiazepines and overdose: retrospective analysis. BMJ 2017;356:j760.CrossRef Sun EC, Dixit A, Humphreys K, Darnall BD, Baker LC, Mackey S. Association between concurrent use of prescription opioids and benzodiazepines and overdose: retrospective analysis. BMJ 2017;356:j760.CrossRef
2.
Zurück zum Zitat Hernandez I, He M, Brooks MM, Zhang Y. Exposure-Response Association Between Concurrent Opioid and Benzodiazepine Use and Risk of Opioid-Related Overdose in Medicare Part D Beneficiaries. JAMA Netw Open 2018;1(2):e180919.CrossRef Hernandez I, He M, Brooks MM, Zhang Y. Exposure-Response Association Between Concurrent Opioid and Benzodiazepine Use and Risk of Opioid-Related Overdose in Medicare Part D Beneficiaries. JAMA Netw Open 2018;1(2):e180919.CrossRef
3.
Zurück zum Zitat Dowell D, Haegerich TM, Chou R. CDC Guideline for Prescribing Opioids for Chronic Pain—United States, 2016. JAMA 2016;315(15):1624.CrossRef Dowell D, Haegerich TM, Chou R. CDC Guideline for Prescribing Opioids for Chronic Pain—United States, 2016. JAMA 2016;315(15):1624.CrossRef
4.
Zurück zum Zitat Genco EK, Forster JE, Flaten H, et al. Clinically Inconsequential Alerts: The Characteristics of Opioid Drug Alerts and Their Utility in Preventing Adverse Drug Events in the Emergency Department. Ann Emerg Med 2016;67(2):240–248.e3.CrossRef Genco EK, Forster JE, Flaten H, et al. Clinically Inconsequential Alerts: The Characteristics of Opioid Drug Alerts and Their Utility in Preventing Adverse Drug Events in the Emergency Department. Ann Emerg Med 2016;67(2):240–248.e3.CrossRef
5.
Zurück zum Zitat Ballo J, Boczenowski MLSS, Mccready BSRG, et al. Pain Management Resources to Support Clinical Decision Support Artifact Development: An Environmental Scan. Agency for Healthcare Research and Quality; 2017. Ballo J, Boczenowski MLSS, Mccready BSRG, et al. Pain Management Resources to Support Clinical Decision Support Artifact Development: An Environmental Scan. Agency for Healthcare Research and Quality; 2017.
Metadaten
Titel
The Association of EHR Drug Safety Alerts and Co-prescribing of Opioids and Benzodiazepines
verfasst von
Laura Barrie Smith, BA
Ezra Golberstein, PhD
Kelly Anderson, RN, BSN
Tori Christiaansen, MD
Nicole Paterson, PharmD BCPS
Sonja Short, MD
Hannah T. Neprash, PhD
Publikationsdatum
22.04.2019
Verlag
Springer US
Erschienen in
Journal of General Internal Medicine / Ausgabe 8/2019
Print ISSN: 0884-8734
Elektronische ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-019-04985-w

Weitere Artikel der Ausgabe 8/2019

Journal of General Internal Medicine 8/2019 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.